FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Acute Adenoviral Conjunctivitis

In brief

The objective of this study is to evaluate the efficacy of FST-100 (PVP-I 0.4% and dexamethasone 0.1%) Ophthalmic Suspension in the treatment of suspected acute adenoviral conjunctivitis.

Key facts

Study ID
NCT00941486
Run by
Shire
People needed
30
Starts
2009-06-30
Expected to finish
2010-06-30
Last updated by the study team
2021-08-24

Who can join

Age: 3 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.